FibroGen, Inc.(NASDAQ : FGEN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-0.37%||8.00||0.7%||$559.23m|
|GILD||Gilead Sciences, Inc.||1.67%||66.87||1.0%||$470.50m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.61%||502.60||2.7%||$458.74m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.77%||219.39||1.9%||$388.60m|
|ALXN||Alexion Pharmaceuticals, Inc.||3.90%||163.68||2.0%||$348.10m|
|EXAS||EXACT Sciences Corp.||-0.37%||130.04||18.4%||$186.19m|
|NBIX||Neurocrine Biosciences, Inc.||1.66%||96.58||4.9%||$179.73m|
|CRSP||CRISPR Therapeutics AG||-4.27%||118.56||0.6%||$166.57m|
FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993 and is headquartered in San Francisco, CA.